We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Drugs as Effective as Surgery for GERD

By HospiMedica staff writers
Posted on 09 Jan 2006
A new study of available data regarding gastroesophageal reflux disease (GERD), concludes that drugs can be just as effective as surgery in managing disease symptoms. More...


GERD occurs when stomach acid backs up into the esophagus, triggering heartburn and sometimes causing esophageal damage. In most patients this is due to a transient relaxation of the "gate” or sphincter that keeps the lower end of the esophagus closed when a person is not swallowing food or liquids.

The findings showed that for chronic GERD, over-the-counter H2 receptor antagonist medications are not as effective as proton pump inhibitors (PPIs), although PPIs have more side effects. PPIs appear to have similar clinical effectiveness when compared to each another. Compared to surgery, PPIs appear to be similarly effective in relieving symptoms and improving quality of life.

Dr. Gerald Berke, a professor of surgery at the University of California, Los Angeles (UCLA, USA), commented on the report. "In general, patients with GERD do respond to both surgical and medical treatment; however, the mainstay of therapy, which is not addressed, is alteration of diet and eating and sleeping habits. In addition, a small, but significant group of patients do not seem to respond to either medical, surgical management, or lifestyle modification, and the reason for their failure rate is currently unknown.”

The study is the first in a series from the Agency for Healthcare Research and Quality (AHRQ, Rockville, MD, USA) that compares treatments for common illnesses. The goal of these studies is to give the public and healthcare workers the latest evidence-based treatment recommendations.

"We are trying to make the information as transparent and as accessible as possible about what we know from the latest science,” said Dr. Carolyn M. Clancy, director of AHRQ, which conducted the study. Future reports will focus on breast cancer screening, drugs for depression, and managing diabetes.






Related Links:
Agency for Healthcare Research and Quality (AHRQ)

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.